SCG101
HBV‑related hepatocellular carcinoma
Phase 1Active
Key Facts
About SCG Cell Therapy
A Singapore biotech engineering pathogen‑specific TCR‑T cell therapies for infection‑linked cancers.
View full company profileHBV‑related hepatocellular carcinoma
A Singapore biotech engineering pathogen‑specific TCR‑T cell therapies for infection‑linked cancers.
View full company profile